Status:
COMPLETED
Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients
Lead Sponsor:
Khyber Teaching Hospital
Conditions:
Diabetic Macular Edema (DME)
Eligibility:
All Genders
32-78 years
Phase:
PHASE4
Brief Summary
Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema
Detailed Description
Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema. Those patients who had glaucoma history or IOP above 21 mm of Hg, Phakic, corneal op...
Eligibility Criteria
Inclusion
- Patients with center involving diabetic macular edema on optical coherence tomography
Exclusion
- Raised intraocular pressure
- History of glaucoma
- Corneal opacity
- Vitreous hemorrhage
- Proliferative diabetic retinopathy
- Anti-VEGF injections in last 3 months
- History of pan-retinal photocoagulation
- Contraindications for anti-VEGF
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2024
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT06882551
Start Date
April 1 2023
End Date
January 15 2024
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Khyber Teaching Hospital
Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000